CG
GSK icon

Cutler Group’s GSK GSK Stock Holding History

Cutler Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,900
Closed -$2K – 3880
2023
Q3 		$2K Buy
2,900
+1,100
+61% +$39K ﹤0.01% 3259
2023
Q2 		$3K Sell
1,800
-500
-22% -$17.9K ﹤0.01% 2851
2023
Q1 		$6K Sell
2,300
-700
-23% -$24.5K ﹤0.01% 2627
2022
Q4 		$12K Buy
3,000
+1,800
+150% +$60K ﹤0.01% 2580
2022
Q3 		$6K Buy
1,200
+880
+275% +$33.4K ﹤0.01% 3500
2022
Q2 		$1K Sell
320
-13,840
-98% -$764K ﹤0.01% 4586
2022
Q1 		$16K Sell
14,160
-16,400
-54% -$891K ﹤0.01% 3237
2021
Q4 		$2K Buy
30,560
+1,040
+4% +$54.1K ﹤0.01% 4732
2021
Q3 		$71K Buy
29,520
+20,320
+221% +$1.02M ﹤0.01% 2206
2021
Q2 		$7K Buy
+9,200
New +$442K ﹤0.01% 4185
2018
Q2 		– Sell
-320
Closed -$1K – 4444
2018
Q1 		$1K Sell
320
-400
-56% -$18.6K ﹤0.01% 4043
2017
Q4 		$7K Sell
720
-3,120
-81% -$144K ﹤0.01% 3382
2017
Q3 		$8K Buy
3,840
+720
+23% +$36.5K ﹤0.01% 3980
2017
Q2 		$3K Hold
3,120
– – ﹤0.01% 5236
2017
Q1 		$7K Buy
3,120
+2,640
+550% +$134K ﹤0.01% 4388
2016
Q4 		$7K Sell
480
-2,720
-85% -$134K ﹤0.01% 4592
2016
Q3 		$13K Buy
3,200
+480
+18% +$26.3K ﹤0.01% 3893
2016
Q2 		$15K Buy
2,720
+2,240
+467% +$118K ﹤0.01% 3666
2016
Q1 		$7K Sell
480
-80
-14% -$3.98K ﹤0.01% 4473
2015
Q4 		$8K Buy
+560
New +$28.5K ﹤0.01% 4395

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cutler Group's GSK Position: Q1 2024 in Review

Cutler Group reduced its GSK (GSK) stake by 98% in Q1 2024, selling an estimated $438K and leaving 249 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

Cutler Group first reported a position in GSK in Q4 2015 and has held it in 17 quarters since. The position peaked at $701K in Q3 2021. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • Cutler Group held 249 shares of GSK worth $10K as of Q1 2024.
  • Cutler Group sold 10,622 GSK shares in Q1 2024, an estimated $438K.
  • GSK made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1273 holding.
  • Cutler Group first reported a position in GSK in Q4 2015 and has held it in 17 quarters since.
  • Cutler Group's GSK position peaked at $701K in Q3 2021.
  • 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.